Physician
Mohsin Ansari MD Faap PC
Mohsin Ansari MD Faap PC was paid $7.37M by Medicaid between Jan 2018 and Dec 2024, across 67 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 52% of everything it billed.
33Billing provider infoMOHSIN ANSARI MD FAAP PC
WINDSOR MILL, MD 21244
WINDSOR MILL, MD 21244
33aNPI1427143536assigned 10/04/2006
33bProvider typePediatrics Physician
28Total paid$7.37M
24GClaims189,543
24DCodes billed67
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Pediatrics Physician providers in Maryland
Rank by total paid#14 of 306
Median peer was paid$206K
This provider vs. median36×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 795 | $31K | |
| 2019 | 576 | $19K | |
| 2020 | 28,754 | $1.18M | |
| 2021 | 32,311 | $1.40M | |
| 2022 | 39,924 | $1.79M | |
| 2023 | 40,084 | $1.87M | |
| 2024incomplete | 47,099 | $1.09M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 52% | 51,137 | 34,361 | $3.80M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 10.0% | 7,309 | 5,505 | $734K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 5.2% | 4,540 | 3,667 | $386K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 5.2% | 4,435 | 3,699 | $383K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 4.1% | 3,298 | 2,629 | $303K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 3.7% | 7,563 | 5,666 | $274K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 3.6% | 3,292 | 2,735 | $269K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 2.7% | 6,205 | 4,988 | $202K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1.1% | 7,296 | 6,045 | $79K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 6,236 | 3,142 | $70K |
| D1206 | Topical application of fluoride varnish | <1% | 3,160 | 2,845 | $67K |
| 90686 | <1% | 3,651 | 3,113 | $62K |
55 more codes
| 92551 | <1% | 7,522 | $58K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 628 | $56K |
| 99050 | <1% | 3,974 | $50K | |
| 90670 | <1% | 2,273 | $47K | |
| 99381 | <1% | 547 | $44K | |
| 90648 | <1% | 1,866 | $38K | |
| 96160 | <1% | 20,172 | $37K | |
| 90633 | <1% | 1,690 | $32K | |
| 90677 | <1% | 644 | $29K | |
| 99051 | <1% | 3,204 | $28K | |
| 90723 | <1% | 1,306 | $27K | |
| 90651 | <1% | 1,392 | $26K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 2,801 | $22K |
| 90710 | <1% | 1,111 | $20K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 518 | $20K |
| 96127 | <1% | 5,994 | $19K | |
| 90697 | <1% | 873 | $18K | |
| 87807 | <1% | 1,625 | $14K | |
| 90734 | <1% | 741 | $14K | |
| 90681 | <1% | 708 | $14K | |
| 81002 | <1% | 6,015 | $13K | |
| 90680 | <1% | 573 | $11K | |
| 99173 | <1% | 6,366 | $11K | |
| 90715 | <1% | 605 | $10K | |
| 0072A | <1% | 266 | $9K | |
| 90696 | <1% | 500 | $9K | |
| 0071A | <1% | 239 | $9K | |
| 90700 | <1% | 427 | $8K | |
| 90619 | <1% | 385 | $7K | |
| 99383 | <1% | 74 | $7K | |
| 96161 | <1% | 2,764 | $6K | |
| 69210 | <1% | 165 | $5K | |
| S0316 | Disease management program, follow-up/reassessment | <1% | 624 | $5K |
| 90685 | <1% | 259 | $4K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 118 | $2K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 60 | $2K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 118 | $1K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 164 | $1K |
| 90716 | <1% | 55 | $1K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 13 | $955.80 |
| 90707 | <1% | 38 | $707.98 | |
| 90620 | <1% | 30 | $642.65 | |
| 81025 | <1% | 58 | $240.42 | |
| 80053 | Comprehensive metabolic panel | <1% | 15 | $148.02 |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 15 | $95.67 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 1,056 | $39.00 |
| 94760 | <1% | 13 | $31.20 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 82 | $17.55 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 51 | $17.40 |
| 91307 | <1% | 341 | $0.20 | |
| 91300 | <1% | 29 | $0.01 | |
| 3210F | 0% | 23 | $0.00 | |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 0% | 69 | $0.00 |
| 99188 | 0% | 26 | $0.00 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 0% | 196 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialANSARI, MOHSIN (PRESIDENT)